Photodynamic therapy in cholangioma - First experiences and perspectives;Photodynamische therapie bei malignen gallengengtumoren - Erfahrungen und perspektiven

Chirurgische Gastroenterologie mit Interdisziplinaren Gesprachen

Volumn 15, Issue 1, 1999, Pages 78-81

  Ortner, M A E J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cholangiocarcinoma; Laser therapy; Photodynamic therapy

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; DISEASE CLASSIFICATION; ENDOSCOPIC THERAPY; INTERMETHOD COMPARISON; LASER SURGERY; MORBIDITY; MORTALITY; PALLIATIVE THERAPY; PHOTODYNAMIC THERAPY; PROGNOSIS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 0032953429     PISSN: 01779990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kremer B, Henn-Bruns D, Vogel I, Grimm H, Soehendra N: Impact of staging on treatment of biliary carcinoma. Endoscopy 1993;25:92-99.
2. Bhuya MMR: Clinicopathologic factors influencing survival of patients with bile duct carcinoma. World J Surg 1993;17:653-657.
3. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R: What constitutes long term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;72:26-34.
4. Smith AC, Dowsett JF, Russell RCG, Hatfield ARW, Cotton PB: Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994;344:1655-1660.
5. Bismuth H, Nakache R, Diamond T: Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-37.
6. Ducreux M, Liguory CL, Lefebre F, Ink O, Choury A, Fritsch J, Bonnell D, Derhy S, Etienne JP: Management of malignant hilar biliary obstruction by endoscopy. Dig Dis Sci 1992;37:778-783.
7. Polydorou A, Cairns SR, Dowsett J, Hatfield ARW, Salmon PR, Cotton PB, Russel RCG: Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 1991;32:685-689.
8. Chang WH, Kortan P, Haber GB: Outcome in patients with bifurcation tumors who undergo unilateral vs bilateral hepatic duct drainage (abstract). Gastrointest Endosc 1996;43:376.
9. Davids PHP, Groen AK, Rauws EA, Tytgat GN, Huibregtse K: Randomised trial of self-expanding metal stents versus polyethylen stents for distal malignant biliary obstruction. Lancet 1992;340:1488-1492.
10. Cendan JC, Zlotecki RA, Vauthey JN: Biliary tract cancer. Curr Opin Gastroenterol 1996;12: 460-465.
11. Doughtery TJ, Potter WR, Weishaupt KR: The structure of the active component of hematoporphyrin derivate. Prog Clin Biol Res 1984;170:301-314.
12. Auler HL, Banzer G: Untersuchungen über die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z Krebsforschung 1942;53:65-68.
13. Kelly JF, Snell ME: Hematoporphyrin derivate: A possible aid in the diagnosis and therapy of carcinoma of the bladder. J Urol 1976;155:150-151.
14. Kato H, Kawaguchi M, Konaka C: Evaluation of PDT in gastric cancer. Laser Med Sci 1986;1:67-74.
15. van Gemert JC, Berenbaum MC, Gijsberts GHM: Wavelength and light-dose dependence in tumor phototherapy with haemtoporphyrin derivate. Br J Cancer 1985;52:43-49.
16. Gomer CJ, Doiron DR, Rucker N, Razum NJ, Fountain SW: Action spectrum (620-640 nm) for hematoporphyrin derivate induced cell killing. Photochem Photobiol 1984;39:365-368.
17. Weishaupt KR, Gomer CJ, Doughtery TJ: Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res 1976;36:2326-2329.
18. Gomer CJ, Razun NJ: Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions. Photochem Photobiol 1984;40:435-439.
19. Valenzu DP: Photomodification of biological membranes with emphasis on singlet oxygen mechanisms. Photochem Photobiol 1987;46:147-160.
20. Zhou C: Mechanism of tumor necrosis induced by photodynamic therapy. J Photochem Photobiol 1989;3:299-318.
21. Okunaka T, Eckhauser ML, Kato H, Bomaminio A, Yamamoto H, Aizawa K, Sarasua MM, Koehler KA: Correlation between photodynamic efficacy of differing porphyrins and membrane partioning behaviour. Laser Surg Med. 1992; 12:98-103.
22. Salet C, Moreno G: Photosensitization of mitochondria: Molecular and cellular aspects. J Photochem Photobiol B 1990;5:133-150.
23. Gomer CJ, Ferrario A, Hayashi N, Rucker N, Szirth BC, Murphree AL: Molecular, cellular, and tissue responses following photodynamic therapy. Laser Surg Med 1988;8:450-463.
24. Fingar VH, Wieman TJ: Studies on the mechanism of photodynamic therapy induced tumor destruction. Proc. SPIE 'Photodynamic Therapy: Mechanism II'. 1990;1203:168-177.
25. Henderson BW, Donovan JM: Release of prostaglandin E2 from cells by photodynamic treatment in vitro. Cancer Res 1989;49:6869, 6890.
26. Shumaker BP, Hetzel FW: Clinical laser photodynamic therapy in the treatment of bladder cancer. Photochem Photobiol 1987;46:899-901.
27. McCaughan JS, Mertens BF, Cho CH, Barabash RD, Payton HW: PDT to treat tumors of the extrahepatic biliary ducts. Arch Surg 1991;126:111-113.
28. Ortner MAEJ, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, Müller JM, Hörtnagl H, Lochs H: Photodynamic therapy of non-resectable cholangiocarcinoma. Gastroenterology 1998;114:536-542.
29. Vauthey JN, Blumgart LH: Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994;14:109-114.
30. Berr F, Tannapfel A, Pahernik S, Wiemann M, Lange K, Halm U, Dellian M, Goetz A, Wittekind Ch, Mössner J: Selective local control of bile duct cancer by photodynamic therapy. J Hepatol 1997;26:A165.